Company Filing History:
1 out of 260 
1 out of 16 Years Active: 2021
Title: Yangmi Lim - Innovator in Cancer Treatment
Introduction
Yangmi Lim is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compositions.
Latest Patents
Yangmi Lim holds a patent for a pharmaceutical composition aimed at inhibiting the metastasis of cancer. This composition includes an antibody that specifically binds to the epidermal growth factor receptor (EGFR). The invention provides a method for inhibiting cancer metastasis, demonstrating effectiveness in reducing the invasion of various gastric cancer cell lines induced by EGFR ligands. This pharmaceutical composition holds promise for use in cancer treatment.
Career Highlights
Throughout his career, Yangmi Lim has worked with reputable organizations, including the Green Cross Corporation and the Mogam Institute for Biomedical Research. His work has focused on developing innovative solutions to combat cancer, showcasing his dedication to improving patient outcomes.
Collaborations
Yangmi Lim has collaborated with notable colleagues, including Jong-hwa Won and Min-Kyu Hur. These partnerships have contributed to the advancement of his research and the development of effective cancer treatments.
Conclusion
Yangmi Lim's contributions to cancer treatment through his innovative patent highlight his role as a significant inventor in the medical field. His work continues to inspire advancements in pharmaceutical compositions aimed at combating cancer metastasis.